Drug profile · INN
tocilizumab
ACTEMRA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
tocilizumab (ACTEMRA) is an FDA-listed pharmaceutical active ingredient. Associated with Hoffmann-La Roche. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN tocilizumab
Brand ACTEMRA
Route INJECTION
Formulation INJECTABLE
ATC code L04AC07
Originator Hoffmann-La Roche
Frequently asked questions
What is tocilizumab?
tocilizumab (ACTEMRA) is an FDA-listed pharmaceutical active ingredient. Associated with Hoffmann-La Roche. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for tocilizumab?
ACTEMRA is a marketed brand name for tocilizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tocilizumab?
tocilizumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.